NGENLA: weekly somatrogon
NGENLA is a long-acting growth-hormone product approved in the U.S. for certain pediatric growth-hormone-deficiency patients. The molecular modification and labeled dose differ from those of SKYTROFA and Sogroya.
Information only. This page does not imply adult approval or local availability.